How has been the historical performance of Mankind Pharma?
Mankind Pharma has shown significant growth from March 2021 to March 2025, with net sales increasing from INR 6,214.43 crore to INR 12,207.44 crore, and profit after tax rising from INR 1,281.35 crore to INR 1,994.35 crore. Total assets surged from INR 6,323.62 crore to INR 27,651.64 crore, reflecting strong financial performance across various metrics.
Answer:The historical performance of Mankind Pharma shows significant growth in various financial metrics over the years.Breakdown:
Mankind Pharma's net sales have increased consistently from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025. The total operating income followed a similar trend, rising from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025. Total expenditure, excluding depreciation, also grew from INR 4,566.33 crore in March 2021 to INR 9,189.51 crore in March 2025. Operating profit (PBDIT) increased from INR 1,819.05 crore in March 2021 to INR 3,554.72 crore in March 2025, reflecting a robust operating profit margin of 24.72% in March 2025. Profit before tax rose from INR 1,679.93 crore in March 2021 to INR 2,504.09 crore in March 2025, while profit after tax increased from INR 1,281.35 crore to INR 1,994.35 crore during the same period. The consolidated net profit also showed an upward trend, reaching INR 1,990.96 crore in March 2025, up from INR 1,265.43 crore in March 2021. Total assets surged from INR 6,323.62 crore in March 2021 to INR 27,651.64 crore in March 2025, with total liabilities increasing from INR 6,323.62 crore to INR 8,483.03 crore. Cash flow from operating activities improved significantly, rising from INR 1,137.00 crore in March 2021 to INR 2,413.00 crore in March 2025, while the closing cash and cash equivalents increased from INR 127.00 crore to INR 403.00 crore over the same period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
